newsfilter
← Latest News
PR Newswire·

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...